206 Assays You Won't Get From The Next Leading Competitor
When it comes to high-throughput kinase selectivity and off-target profiling, KINOMEscan™ is redefining the standard.
Our proprietary active-site dependent competition binding technology delivers the industry’s largest commercial collection of
human kinase assays, which includes the most comprehensive panel of tyrosine, lipid, and clinically-relevant mutant kinases available.
Below are the results of the comparison between KINOMEscan
and the next leading competitor and it's clear: there are
206 assays
that they don't offer and
130 that are available only from KINOMEscan. It is no surprise that more researchers are turning to KINOMEscan to help
drive their discovery and SAR.
Request a quote now, and let KINOMEscan™ show you what you have been missing!
• Largest
commercially available kinase assay panel
• Flexible screening options
• Economical
• Standardized assay conditions
Circles represent all kinase assays currently available in the KINOMEscan panel; blue circles represent assays missing from the next leading competitor's panel. Mutant and lipid kinases are not mapped.
|